Cargando…
Autoantibody profiles are associated with specific clinical features in psychotic disorders
INTRODUCTION: Immune system abnormalities exist across a range of psychiatric disorders. Autoimmunity, characterized by the production of antibodies against the body’s own antigens, is a feature of immune system dysfunction and could play a role in mental disorder pathophysiology. Better understandi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480266/ http://dx.doi.org/10.1192/j.eurpsy.2021.2026 |
_version_ | 1784791013993218048 |
---|---|
author | Schubert, K.O. Falk, A. Jernbom Galletly, C. Just, D. Toben, C. Baune, B. Clark, S. Liu, D. Nilsson, P. Manberg, A. |
author_facet | Schubert, K.O. Falk, A. Jernbom Galletly, C. Just, D. Toben, C. Baune, B. Clark, S. Liu, D. Nilsson, P. Manberg, A. |
author_sort | Schubert, K.O. |
collection | PubMed |
description | INTRODUCTION: Immune system abnormalities exist across a range of psychiatric disorders. Autoimmunity, characterized by the production of antibodies against the body’s own antigens, is a feature of immune system dysfunction and could play a role in mental disorder pathophysiology. Better understanding of the associations of auto-immunoglobulin G (IgG) repertoires with clinical features of mental illness could yield novel models of psychosis pathophysiology and markers for biological patient stratification. OBJECTIVES: To undertake global screening for auto-IgG expression in a large cohort of people with psychotic disorders; to determine whether associations exist between autoantibody expression and clinical features. METHODS: Cross-sectional quantification of auto-IgGs in blood plasma of 461 people with established psychotic disorder diagnoses. For global screening, pooled samples of phenotypically representative patient groups were exposed to planar protein microarrays containing 42,000 human antigens. For targeted profiling, expression levels of 380 autoantibodies were quantified by suspension bead array (SBA) in each patient’s plasma. RESULTS: We identified highly individual autoantibody profiles with no evidence for co-expression patterns. We found 6 autoantibodies robustly associated with specific psychopathology: anti-AP3B2, detected in 5% of the cohort of whom 100% had persecutory delusions; anti-TDO2 (5% of the cohort, 100% hallucinations); anti-CRYGN (4%, 86% initial insomnia); anti-APMAP (3%, 86% poor appetite); anti-OLFM1 (2.5%, 100% above median cognitive function); and anti-WHAMMP3 (2%, 90% anhedonia and dysphoria). Examination of the auto-IgG binding site on the TDO2 protein revealed a putative pathophysiological mechanism involving the kynurenine pathway. CONCLUSIONS: We identified 6 frequently occurring autoantibodies that were associated with specific clinical features in people with psychotic disorders. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9480266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94802662022-09-29 Autoantibody profiles are associated with specific clinical features in psychotic disorders Schubert, K.O. Falk, A. Jernbom Galletly, C. Just, D. Toben, C. Baune, B. Clark, S. Liu, D. Nilsson, P. Manberg, A. Eur Psychiatry Abstract INTRODUCTION: Immune system abnormalities exist across a range of psychiatric disorders. Autoimmunity, characterized by the production of antibodies against the body’s own antigens, is a feature of immune system dysfunction and could play a role in mental disorder pathophysiology. Better understanding of the associations of auto-immunoglobulin G (IgG) repertoires with clinical features of mental illness could yield novel models of psychosis pathophysiology and markers for biological patient stratification. OBJECTIVES: To undertake global screening for auto-IgG expression in a large cohort of people with psychotic disorders; to determine whether associations exist between autoantibody expression and clinical features. METHODS: Cross-sectional quantification of auto-IgGs in blood plasma of 461 people with established psychotic disorder diagnoses. For global screening, pooled samples of phenotypically representative patient groups were exposed to planar protein microarrays containing 42,000 human antigens. For targeted profiling, expression levels of 380 autoantibodies were quantified by suspension bead array (SBA) in each patient’s plasma. RESULTS: We identified highly individual autoantibody profiles with no evidence for co-expression patterns. We found 6 autoantibodies robustly associated with specific psychopathology: anti-AP3B2, detected in 5% of the cohort of whom 100% had persecutory delusions; anti-TDO2 (5% of the cohort, 100% hallucinations); anti-CRYGN (4%, 86% initial insomnia); anti-APMAP (3%, 86% poor appetite); anti-OLFM1 (2.5%, 100% above median cognitive function); and anti-WHAMMP3 (2%, 90% anhedonia and dysphoria). Examination of the auto-IgG binding site on the TDO2 protein revealed a putative pathophysiological mechanism involving the kynurenine pathway. CONCLUSIONS: We identified 6 frequently occurring autoantibodies that were associated with specific clinical features in people with psychotic disorders. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9480266/ http://dx.doi.org/10.1192/j.eurpsy.2021.2026 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Schubert, K.O. Falk, A. Jernbom Galletly, C. Just, D. Toben, C. Baune, B. Clark, S. Liu, D. Nilsson, P. Manberg, A. Autoantibody profiles are associated with specific clinical features in psychotic disorders |
title | Autoantibody profiles are associated with specific clinical features in psychotic disorders |
title_full | Autoantibody profiles are associated with specific clinical features in psychotic disorders |
title_fullStr | Autoantibody profiles are associated with specific clinical features in psychotic disorders |
title_full_unstemmed | Autoantibody profiles are associated with specific clinical features in psychotic disorders |
title_short | Autoantibody profiles are associated with specific clinical features in psychotic disorders |
title_sort | autoantibody profiles are associated with specific clinical features in psychotic disorders |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480266/ http://dx.doi.org/10.1192/j.eurpsy.2021.2026 |
work_keys_str_mv | AT schubertko autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT falkajernbom autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT galletlyc autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT justd autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT tobenc autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT bauneb autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT clarks autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT liud autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT nilssonp autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders AT manberga autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders |